HomeEKTA-B • STO
add
Elekta AB (publ)
Previous close
kr 49.40
Day range
kr 49.20 - kr 49.94
Year range
kr 44.50 - kr 87.35
Market cap
18.41B SEK
Avg Volume
1.47M
P/E ratio
80.56
Dividend yield
4.80%
Primary exchange
STO
In the news
Financials
Income Statement
Revenue
Net income
| (SEK) | Apr 2025info | Y/Y change |
|---|---|---|
Revenue | 5.16B | 2.65% |
Operating expense | 1.24B | 3.24% |
Net income | -386.00M | -193.01% |
Net profit margin | -7.49 | -190.68% |
Earnings per share | 1.11 | -3.48% |
EBITDA | 981.00M | 23.86% |
Effective tax rate | -24.10% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Apr 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.96B | 6.33% |
Total assets | 28.98B | -7.75% |
Total liabilities | 20.13B | -2.45% |
Total equity | 8.85B | — |
Shares outstanding | 382.08M | — |
Price to book | 2.14 | — |
Return on assets | 6.71% | — |
Return on capital | 11.51% | — |
Cash Flow
Net change in cash
| (SEK) | Apr 2025info | Y/Y change |
|---|---|---|
Net income | -386.00M | -193.01% |
Cash from operations | 1.57B | 19.06% |
Cash from investing | -319.00M | 28.48% |
Cash from financing | -1.64B | -214.53% |
Net change in cash | -628.00M | -247.07% |
Free cash flow | 786.25M | -5.80% |
About
Elekta is a global Swedish company that develops and produces radiation therapy and radiosurgery-related equipment and clinical management for the treatment of cancer and brain disorders. Elekta has a global presence in more than 120 countries, with over 40 offices around the world and about 4,700 employees. Wikipedia
Founded
1972
Website
Employees
4,536
